Dynavax Gets Word from FDA on HEPLISAV Hepatitis B Vaccine - Trading Markets (press release) |
|
|
... the clinical hold on the two HEPLISAV Investigational New Drug (IND) Applications, for healthy adults and patients with end-stage renal disease (ESRD). ... read more
|